Related Experiment Video
Updated: May 8, 2025
Application of Laser Microdissection to Uncover Regional Transcriptomics in Human Kidney Tissue
Published on: June 9, 2020
Decoding Kidney Pathophysiology: Omics-Driven Approaches in Precision Medicine
Charlotte Delrue1, Marijn M Speeckaert1,2
1Department of Nephrology, Ghent University Hospital, 9000 Ghent, Belgium.
Abstract:
Chronic kidney disease (CKD) is a major worldwide health concern because of its progressive nature and complex biology. Traditional diagnostic and therapeutic approaches usually fail to account for disease heterogeneity, resulting in low efficacy. Precision medicine offers a novel approach to studying kidney disease by combining omics technologies such as genomics, transcriptomics, proteomics, metabolomics, and epigenomics. By identifying discrete disease subtypes, molecular biomarkers, and therapeutic targets, these technologies pave the way for personalized treatment approaches. Multi-omics integration has enhanced our understanding of CKD by revealing intricate molecular linkages and pathways that contribute to treatment resistance and disease progression. While pharmacogenomics offers insights into expected responses to personalized treatments, single-cell and spatial transcriptomics can be utilized to investigate biological heterogeneity. Despite significant development, challenges persist, including data integration concerns, high costs, and ethical quandaries. Standardized data protocols, collaborative data-sharing frameworks, and advanced computational tools such as machine learning and causal inference models are required to address these challenges. With the advancement of omics technology, nephrology may benefit from improved diagnostic accuracy, risk assessment, and personalized care. By overcoming these barriers, precision medicine has the potential to develop novel techniques for improving patient outcomes in kidney disease treatment.
Insights
Precision medicine uses multi-omics to understand chronic kidney disease (CKD) heterogeneity. This approach aims to improve diagnosis, identify biomarkers, and personalize treatments for better patient outcomes.
Area of Science:
- Nephrology
- Genomics
- Proteomics
- Metabolomics
- Epigenomics
Background:
- Chronic kidney disease (CKD) is a global health issue with complex biology and progressive nature.
- Current diagnostic and therapeutic methods often lack efficacy due to disease heterogeneity.
- Precision medicine offers a personalized approach to kidney disease research and treatment.
Purpose of the Study:
- To explore the role of precision medicine in understanding and treating chronic kidney disease.
- To highlight the application of multi-omics technologies in identifying CKD subtypes and therapeutic targets.
- To discuss the potential of personalized treatment strategies for improving patient outcomes.
Main Methods:
- Integration of multi-omics data, including genomics, transcriptomics, proteomics, metabolomics, and epigenomics.
- Application of pharmacogenomics for predicting treatment responses.
- Utilizing single-cell and spatial transcriptomics to analyze biological heterogeneity.
Main Results:
- Multi-omics integration enhances understanding of CKD by revealing molecular pathways involved in progression and treatment resistance.
- Identification of discrete disease subtypes, molecular biomarkers, and potential therapeutic targets.
- Insights into biological heterogeneity and personalized treatment responses.
Conclusions:
- Precision medicine, through multi-omics, offers a promising avenue for advancing CKD diagnosis, risk assessment, and personalized care.
- Overcoming challenges like data integration, cost, and ethical considerations is crucial for realizing its full potential.
- Development of standardized protocols, data-sharing frameworks, and advanced computational tools will drive innovation in nephrology.
